120 related articles for article (PubMed ID: 12420241)
1. Hirudin for prophylaxis and treatment of deep vein thrombosis.
Kemkes-Matthes B
Semin Thromb Hemost; 2002 Oct; 28(5):455-8. PubMed ID: 12420241
[TBL] [Abstract][Full Text] [Related]
2. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
Haas S
Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
[TBL] [Abstract][Full Text] [Related]
3. Recombinant hirudin in the prevention of venous thromboembolism in patients undergoing elective hip surgery.
Agnelli G; Sonaglia F
Semin Thromb Hemost; 1997; 23(2):143-8. PubMed ID: 9200338
[TBL] [Abstract][Full Text] [Related]
4. Hirudins for prophylaxis and treatment of venous thromboembolism.
Prisco D; Falciani M; Antonucci E; Gensini GF
Semin Thromb Hemost; 2001 Oct; 27(5):543-9. PubMed ID: 11668426
[TBL] [Abstract][Full Text] [Related]
5. Hirudin in acute coronary syndromes.
van de Loo A; Bode C
Semin Thromb Hemost; 2002 Oct; 28(5):459-66. PubMed ID: 12420242
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
Schiele F; Lindgaerde F; Eriksson H; Bassand JP; Wallmark A; Hansson PO; Grollier G; Sjo M; Moia M; Camez A; Smyth V; Walker M
Thromb Haemost; 1997 May; 77(5):834-8. PubMed ID: 9184388
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
8. Biological relevance of anti-recombinant hirudin antibodies--results from in vitro and in vivo studies.
Liebe V; Brückmann M; Fischer KG; Haase KK; Borggrefe M; Huhle G
Semin Thromb Hemost; 2002 Oct; 28(5):483-90. PubMed ID: 12420244
[TBL] [Abstract][Full Text] [Related]
9. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
Heidenreich C; Hohmann V; Bramlage P
Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
[TBL] [Abstract][Full Text] [Related]
10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: a critical risk/benefit analysis of patients in intensive care treated with R-hirudin.
Schenk JF; Berg G; Mörsdorf S; Stefan B; Kroll H; Krischek B; Pindur G; Schieffer H; Wenzel E
Clin Appl Thromb Hemost; 2000 Jul; 6(3):151-6. PubMed ID: 10898275
[TBL] [Abstract][Full Text] [Related]
12. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
13. Initial treatment of venous thromboembolism.
McRae SJ; Ginsberg JS
Circulation; 2004 Aug; 110(9 Suppl 1):I3-9. PubMed ID: 15339875
[TBL] [Abstract][Full Text] [Related]
14. Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery.
Glotzbecker MP; Bono CM; Harris MB; Brick G; Heary RF; Wood KB
Spine (Phila Pa 1976); 2008 Dec; 33(26):2915-21. PubMed ID: 19092624
[TBL] [Abstract][Full Text] [Related]
15. [The prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practice].
Hirmerová J
Vnitr Lek; 2006 Apr; 52(4):379-88. PubMed ID: 16755994
[TBL] [Abstract][Full Text] [Related]
16. The use of intravenous recombinant hirudin in the treatment of deep vein thrombosis in a patient with an acute heparin allergy.
Fields RM; Peppo W
Ann Emerg Med; 2002 Aug; 40(2):155-8. PubMed ID: 12140493
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolic risk and its prevention in hospitalized medical patients.
Haas SK
Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis and treatment of deep vein thrombosis in general surgery.
Gutt CN; Oniu T; Wolkener F; Mehrabi A; Mistry S; Büchler MW
Am J Surg; 2005 Jan; 189(1):14-22. PubMed ID: 15701484
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism prophylaxis in medical patients: future perspectives.
Imberti D; Prisco D
Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulants in the treatment of deep vein thrombosis.
Merli G
Am J Med; 2005 Aug; 118 Suppl 8A():13S-20S. PubMed ID: 16125510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
